ELTP Opinions 08/25/2014 02:29:29 $ELTP total

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
ELTP Opinions 08/25/2014 02:29:29 $ELTP
total nonsense
Two BIG Pharma's went out of their way to contact Elite.
The negotiations have been on going.
ELTP's buyout price rising with each passing day.
Listen to last few CC's

ELTP Stock Message Board http://investorshangout.com/Elite-Pharmaceuti...LTP-61177/

Unidentified Analyst

Given that Elite’s generic NDA ART line takes less time and money to bring to market then Elite’s once daily ELI-216 product can you speak to what the current plans are for this product say for instance to partner a combo ELI-201 and ELI-216 together and how quickly you are planning to move forward with this product as there is no once-daily abuse resistant product on the market to date


Doug Plassche - Executive Vice President-Operations
Obviously that’s a very interesting question and I think about that a lot, to take products like this to market by ourselves would require a lot of money. Mr. Ward here thinks day and night on how he can get me another $50 million, but definitely all options are on the table and I have no issue and I have talked to other companies about partnering with us in order to cover the clinical trial cost


But But But But, Big Pharma loves Elite. Well maybe likes Elite? Oh No, Big Pharma could care less about Elite! I suspected it was all hype.
CEO has enough funds NOW for 4-5 ADT opiods. These drugs will be generating BILLIONS. No need for additional shares.

ELI-201 will launch my retirement
Its is clear that investors, long and otherwise, agree with the potential buyer that Elite is way over valued. Both are reflected one by no buyer and the other by the buy orders usually all way below the BID.
AMEN to all of that. CEO will attempt to go it alone if he has to issue 5B more shares. He apparently doesn't like generics but he liked them enough to dump 12 of them on to Elite for a very generous price, thanks to JT.
Why is Nasrat trying to be so cocky??? Just sign with a big pharma and be done with it.

He's going to end up screwing up the launch of ELI-200 or something else bad is going to happen.

We are too small to be thinking we can just do it alone.

WE CAN'T EVEN LAUNCH FDA APPROVED GENERICS ON TIME!!!!!!!!!!!!!!!!!!!!!
Nobody cares about where this stock goes tomorrow, next week, or next month.

Shareholders are waiting for the buyout so they get the MAX RETURN for their investment.

Call me when we get bought out.

Couldn't care less what happens until then.
As long as Elite and the FDA gets along well !!!! As far as a buyout, there of course must be an agreed price and Nasrat may feel Elite is much more valuable than a buyer feels it is ... Either way as long as Elite gets FDA approval we are in the $$$$$


IB_
Last week of August!! Let the good times roll! This week will be interesting with different parties jockeying for position before Autumn. Locked and loaded and ready for football and ELTP INCREASES!!!!!!
The longer Nasrat goes it alone the greater the value of ELITE becomes, and the lower the risk for the acquiring company.


Are you coinciding this with your appearance at the Rodman Conference to have substantial presentation there with new products from Elite.


Nasrat Hakim - President and Chief Executive Officer
That really sound like it is, but it’s not. The Rodman Conference is early in the month, its eighth through tenth I believe. And the results that we are getting will be towards the end of the month and the final the reports will be in October

Starting to look like Elite may not have that "ONE Big Pharma" partner merging or buying out Elite as Nasrat now says we are going it alone !!!!


IB_
Only ONE Big Pharma will end up liking ELTP.

The ONE who ends up partnering, merging or buying out Elite.

The rest don't need the competition ...


ELTP
living for ELI-201
Smells like heavy accumulation before the next run occurs that we all know is coming shortly.
TD Ameritrade is better.

Quote:
Yeah I agree ELTP GREEN $$$$$$$$$ in my fidelity account. Notice the lack of question mark. LOL LOL

JT extended a very lucrative good deal; way more than the previously non performance (not being produced) drugs were worth.
I haven't sold any shares either. Both Nasrat and I know the buyout is coming in a few years and that is what we are waiting for. Great minds think alike.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

k-ID's Kai SDK: Age-Adaptive Design Revolution

Updated Category News Views 48

New Horizons for Developers Today, if you're building an app, you're just as likely to be wrangling with legal regulations as you are writing code. That's where k-ID’s new SDK, Kai, comes into play—it's not just another tool in the shed, it’s the whole toolbox for dealing with age-specific app requirements everywhere. The Changing App Landscape Why does this matter?...

Continue Reading
Qloo's AI Reveals Overlooked EV Market Opportunities

Updated Category News Views 77

Uncovering Surprising Market Overlaps Ever thought the guy barreling through mud in his rugged 4x4 might have more in common with an electric vehicle enthusiast than we'd usually guess? That's the curveball Qloo and Kearney are tossing at us. Their latest study shakes up the tired old assumptions floating around the automotive sector about who's buying what and why. Using...

Continue Reading
Epson Innovates Order Pickup at Florida Food Hall

Updated Category News Views 126

Changing the Food Hall Game Innovation isn't just a Silicon Valley buzzword; it found its place at the Central Park St. Pete Food Hall in Florida. These guys have figured out the magic formula to streamline multi-vendor dining with Epson's point-of-sale label printers. We're talking about keeping guests from playing musical chairs with food orders, folks. It's a...

Continue Reading
Beta Bionics Faces Class Action Over iLet Device Concerns

Updated Category News Views 69

Securities Fraud Allegations Hit Beta Bionics Here's a fresh one on the market front—Beta Bionics is in hot water, and it's not looking pretty. The ticker NASDAQ:BBNX is swirling in the chaos of a class action lawsuit, thanks to a stock tumble that would make even seasoned traders cringe. What's got investors riled up? The nitty-gritty centers on accusations that the...

Continue Reading
Co-Diagnostics Nearing India TB Test Launch By 2026

Updated Category News Views 98

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

Continue Reading
North Fork Mono Casino Opens: A $750 Million Bet

Updated Category News Views 57

A New Spin in Madera Cue the fanfare, folks! The North Fork Mono Casino just threw open its doors earlier than expected today, marking a hefty $750 million wager right in the heart of California's Central Valley. It's a big deal managed by Station Casinos, part of Red Rock Resorts, Inc. (NASDAQ: RRR)—teaming up with the North Fork Rancheria of Mono Indians for a...

Continue Reading
Ensign Group Faces Securities Fraud Lawsuit Amid Scandal

Updated Category News Views 92

Ensign's Legal Storm: Investors on Edge Man, you can't ignore the weighty allegations pounding on Ensign Group's door right now. The skilled nursing giant, under the ticker NASDAQ:ENSG, is feeling the heat from a securities class action filed against them, and my gut tells me this isn't going to blow over quietly. This case sure looks like a financial tempest that could...

Continue Reading
Billd's Flex Line: Game-Changer for Subcontractor Credit

Updated Category News Views 103

Billd's Bold Move Across America Forget piecemeal rollouts; Billd's taking their latest brainchild, Flex Line, right into the heart of America's subcontractor landscape. This isn't some flash-in-the-pan financial offering, either—it's a heavy-hitter poised to shake up the way subcontractors wrangle their working capital. We're talking about a line of credit that's as...

Continue Reading
SK hynix Hits $104 Trillion in Revenue, Boosts Dividends

Updated Category News Views 10

Phenomenal Financial Benchmark You gotta give it to SK hynix. They've just blown past that 100 trillion won ceiling like it's a minor bump on the highway. For folks tracking big numbers in memory semiconductors, this is fireworks-worthy. We're talking 104.6155 trillion won in revenue, a solid 83.3338 trillion won in operating profit, and a 39.7756 trillion won net profit....

Continue Reading
Johnson Controls FY26 Results Highlight Growth Momentum

Updated Category News Views 212

Unpacking Johnson Controls' Fiscal 2026 Performance You know, it's not often that a company hits a home run with back-to-back quarters, but Johnson Controls (NYSE:JCI) seems to be swinging for the fences as they wrap up fiscal 2026. What we've got here is a robust set of financial results, showcasing not just growth but momentum that's got investors humming. We're talking...

Continue Reading

Top 5 Most Recently Viewed Articles

US National Debt Surpasses $38 Trillion: Key Insights Ahead

Updated Category News Views 302

US National Debt Surges Past $38 Trillion As the federal government encounters a shutdown, the U.S. gross national debt has topped $38 trillion, according to the latest Treasury data, causing widespread concern over the country's financial health. Rapid Escalation of Debt Since 2000 This increase in debt represents the fastest rise outside the COVID-19 pandemic period....

Continue Reading
Guardian Metal Resources Unearths High-Grade Tungsten Finds

Updated Category News Views 276

Guardian Metal Resources Excels in Tungsten Discovery Guardian Metal Resources plc (LON:GMET, OTCQX:GMTLF) is making waves in the mineral exploration world with impressive tungsten assay results from its Pilot Mountain project. Based in Nevada, this company specializes in uncovering valuable mineral resources, and their latest findings showcase not only their commitment...

Continue Reading
West Cancer Center Pioneers Holographic Patient Consultations

Updated Category News Views 152

West Cancer Center Introduces Innovative Holographic Consultations West Cancer Center & Research Institute has teamed up with Proto Inc. to launch an exciting new initiative: the first-ever holographic consultations between doctors and patients. This groundbreaking achievement was unveiled at a prominent event at UC Berkeley, which centered on Global Healthcare...

Continue Reading
PJT Partners Achieves Record Stock Price with Strong Growth

Updated Category News Views 75

PJT Partners Hits All-Time High Stock Price PJT Partners Inc. has reached the impressive milestone of a stock price soaring to an all-time high of $137.24. This remarkable achievement exhibits the confidence investors have in this global advisory-focused investment bank. Over the past year, PJT Partners has experienced an extraordinary 75.12% increase in its stock value,...

Continue Reading
Wyndham Hotels & Resorts Welcomes New Director Alexandra Jung

Updated Category News Views 140

Wyndham Hotels & Resorts Welcomes New Addition to Board Wyndham Hotels & Resorts, a prominent name in the hospitality industry, recently announced the exciting appointment of Alexandra A. Jung to its Board of Directors. This decision highlights the company's commitment to enhancing its governance and operational effectiveness. About Alexandra A. Jung Alexandra A. Jung...

Continue Reading